Skip to content

A DRIVEN DEVELOPER OF ‘PASSIVELY SMART’ SPINAL IMPLANT SYSTEMS

Founded in 2009, Cutting Edge Spine’s mission is to develop and commercialize transformational orthopedic fixation systems that are ‘passively smart’ in nature and focused upon real improvement in clinical outcomes associated with orthopedic fixation while at the same time respecting the fiscal value concerns of the marketplace.

The First In The Industry

Cutting Edge Spine has demonstrated its commitment to the development and commercialization of futuristic spinal technologies in pursuit of better patient care outcomes having been ‘first to market’ in the U.S with several bio-active materials in addition to novel fixation that potentially provide better early onset bone apposition to implants.  

EXTENSIVE TRABECULAR TECHNOLOGY PATENT PORTFOLIO

Cutting Edge Spine has attained an extreme position of strength relative to the granting of an extensive patent portfolio for trabecular fixation relative to all orthopedic applications. Leveraging this strong patent position, combined with the vast company acuity
that comes from Cutting Edge Spine being the first to market with novel bio-active materials, affords Cutting Edge Spine a very unique position both today and forgoing.

TRANSFORMATIONAL, EFFECTIVE, AND SAFE

RESEARCH DEVELOPMENT

To stay on the cutting edge of spinal innovation, CES reinvests a substantial percentage of its annual revenues back into the research and development of new innovative technologies.

QUALITY ASSURANCE

Quality and risk management are a key ingredients of the Cutting Edge Spine value proposition. Our relentless commitment and continuous progression of our quality system is unparalleled as we use validated production processes that ensure first-in-class quality.

CLINICAL EFFICACY

The collection of clinical data is at the core of CES’s mission to provide better spinal technologies geared towards better clinical outcomes.

OUR LATEST INFORMATION

Information From Our Latest Press Releases

Cutting Edge Spine Announces Noticeof Issuance from the U.S. Patent andTrademark Office regarding Patent No.US 11,771,482 B2: IMPLANTS FORTISSUE FIXATION AND FUSION

Orthopedic Trabecular Fixation Screw This patent issuance further solidifies Cutting Edge Spine as an industry leader relative to trabecular fixation for orthopedic applications. Mineral Springs, North Carolina, a leader in

How One Company Tackled 3DPrinting Spine Implants

The design and development of orthopedic implants takes a significant amount of time, money and labor. According to Randy Roof, the President, CEO and Founder of Cutting Edge Spine (CES),

Cutting Edge Spine Announces Notice of Issuance from the U.S. Patent and Trademark Office regarding Patent No. US 10,993,754 B2: IMPLANTS FOR TISSUE FIXATION AND FUSION

This patent issuance solidifies Cutting Edge Spine as an industry leader in 3D printed trabecular fixation for orthopedic applications. Mineral Springs, NC June 17, 2020 Cutting Edge Spine (https://cuttingedgespine.com), a

Cutting Edge Spine Announces FDA 510(K) Clearance of its New HA Enhanced PEEK Interbody System for a Direct Lateral Approach to the Spine, the EVOL®ha-DLIF

Cutting Edge Spine, a leader in the development and commercialization of bioactive spinal solutions, today announced the 510(K) clearance and commercial launch of the latest addition to its bioactive portfolio

FDA 510(K) Clearance of its EVOL-SI Joint Fusion System

The commercialization of the EVOL-SI system addresses the needs of orthopedic surgeons and neurosurgeons seeking superior clinical outcomes following sacral-iliac surgery. Waxhaw, NC August 20, 2019 Cutting Edge Spine (https://cuttingedgespine.com),

FDA 510(K) Clearance of its New HA Enhanced PEEK Interbody for the Cervical Spine, the EVOL ha-C

Cutting Edge Spine, a US leader in the development and commercialization of bio-active technologies for the spine, today announced the 510(k) clearance and commercial launch of it’s latest innovation, the
"Cutting Edge Spine is providing the marketplace today with futuristic fixation technology that is highly differentiated, patent protected, and transformational in nature. Our ability to leverage our strong patent position relative to trabecular fixation for all orthopedic applications affords us the ability to do things from a development perspective that others simply can’t do without potential repercussions."

Randy Roof – President & CEO; Founder